fluoxetine has been researched along with clonazepam in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (40.54) | 18.2507 |
| 2000's | 8 (21.62) | 29.6817 |
| 2010's | 12 (32.43) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cotreau, MM; Greenblatt, DJ; Harmatz, JS; Horst, WD; Preskorn, SH | 1 |
| Bakish, D | 1 |
| Kingsbury, SJ; Puckett, KM | 1 |
| Dominguez, RA; Mestre, SM | 1 |
| Hammerness, PG; Kaspi, SP; Otto, MW; Pollack, MH; Rosenbaum, JF | 1 |
| Friedenberg, FK; Rothstein, KD | 1 |
| Serra-Mestres, J; Shapleske, J; Tym, E | 1 |
| Bakouche, O; Domer, P; Gordon, KB; Guitart, J; Kuzel, T; Roenigk, H; Rosen, S; Salard, D | 1 |
| Jefferson, JW | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Benazzi, F | 1 |
| Glaudin, V; Londborg, PD; Painter, JR; Smith, WT | 3 |
| Furukawa, T | 1 |
| Churchill, LE; Connor, KM; Davidson, JR; Foa, EB | 1 |
| Harasztosi, C; Kecskeméti, V; Nánási, PP; Pál, B; Riba, P; Rusznák, Z; Szûcs, G; Wagner, R | 1 |
| Connor, KM; Davidson, JR; Sheehan, DV; Sheehan, KH; Vaishnavi, S | 1 |
| Salo, R; Wolf, J | 1 |
| Fontenelle, LF; Leite, MA | 1 |
| Ameral, VE; Baer, L; Brintz, C; Clain, A; Fava, M; Glaudin, V; Londborg, PD; Painter, JR; Papakostas, GI; Smith, WT | 1 |
| Bhatia, MS; Jhanjee, A; Kumar, P; Srivastava, S | 1 |
| Işik, U; Korkmaz, H; Korkmaz, S | 1 |
| Lin, CC; Lin, HY; Liu, CC | 1 |
| Müller, CJ; Schenberg, LC; Schimitel, FG; Tufik, S | 1 |
| Aragones, JM; Blanch, CE; Escote-Llobet, S; Guillen-Font, A | 1 |
| Bonan, CD; Lara, DR; Piato, AL; Schaefer, IC; Siebel, AM; Vianna, MR | 1 |
| Bhave, S; Faye, A; Gawande, S; Kirpekar, V; Tadke, R | 1 |
| Gupta, T; Jain, S; Nebhinani, N; Singhai, K; Suthar, N | 1 |
| Walden, J | 1 |
| Kenda, M; Sollner Dolenc, M; Zore, T | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
6 review(s) available for fluoxetine and clonazepam
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of treatment-refractory obsessive compulsive disorder patients.
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Clonazepam; Combined Modality Therapy; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Treatment Outcome | 1994 |
Social phobia: everyone's disorder?
Topics: Adrenergic beta-Antagonists; Blushing; Clinical Trials as Topic; Clonazepam; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Phobic Disorders; Prevalence; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
6 trial(s) available for fluoxetine and clonazepam
| Article | Year |
|---|---|
Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Clonazepam; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans; Male; Reference Values | 1992 |
Cognitive behavior therapy for treatment-refractory panic disorder.
Topics: Adult; Alprazolam; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Pilot Projects; Psychiatric Status Rating Scales; Psychotherapy, Group; Treatment Outcome | 1994 |
Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
Topics: Adult; Ambulatory Care; Clonazepam; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; GABA Modulators; Humans; Patient Compliance; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide Prevention | 1998 |
Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression.
Topics: Adult; Aged; Anxiety; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Time Factors; Treatment Outcome | 2000 |
Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Anxiety; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Outpatients; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2002 |
Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Clonazepam; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Treatment Outcome | 2010 |
25 other study(ies) available for fluoxetine and clonazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Fluoxetine potentiation by buspirone: three case histories.
Topics: Adult; Buspirone; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Trazodone; Tryptophan | 1991 |
Effects of fluoxetine on serum clozapine levels.
Topics: Adult; Clonazepam; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Fluoxetine; Humans; Lorazepam; Male; Schizophrenia, Paranoid | 1995 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; Comorbidity; Female; Fluoxetine; Humans; Male; Mental Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Prevalence | 1994 |
Hepatitis secondary to fluoxetine treatment.
Topics: Adult; Anxiety Disorders; Chemical and Drug Induced Liver Injury; Clonazepam; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1996 |
Treatment of palilalia with trazodone.
Topics: Adult; Anxiety Disorders; Chemical and Drug Induced Liver Injury; Clonazepam; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1996 |
Pseudo-mycosis fungoides in a patient taking clonazepam and fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Clonazepam; Diagnosis, Differential; Drug Eruptions; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms | 1996 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Antidepressant-benzodiazepine combination therapy.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 1999 |
Hyperhidrosis in social anxiety disorder.
Topics: Acetates; Adult; Amines; Calcium Channel Blockers; Clinical Trials as Topic; Clonazepam; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Female; Fluoxetine; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperhidrosis; Male; Phobic Disorders; Prognosis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2002 |
Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
Topics: Animals; Anticonvulsants; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Clonazepam; Cochlear Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Fluoxetine; Male; Membrane Potentials; Mice; Neurons, Afferent; Patch-Clamp Techniques; Phenytoin; Selective Serotonin Reuptake Inhibitors | 2005 |
Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Clonazepam; Cross-Sectional Studies; Female; Fluoxetine; Follow-Up Studies; Health Surveys; Humans; Interviews as Topic; Male; Middle Aged; Personality Inventory; Phobic Disorders; Psychometrics; Reference Values; Reproducibility of Results; Risk Factors; Stress Disorders, Post-Traumatic; Stress, Psychological; United States | 2007 |
Water, water, everywhere, nor any drop to drink: climate change delusion.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Climate; Clonazepam; Dehydration; Delusions; Depressive Disorder; Fluoxetine; GABA Modulators; Greenhouse Effect; Humans; Male; Olanzapine; Psychotic Disorders; Water Supply | 2008 |
Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
Topics: Adult; Antipsychotic Agents; Atrophy; Caudate Nucleus; Clonazepam; Clozapine; Dibenzothiazepines; Electromyography; Fluoxetine; Humans; Magnetic Resonance Imaging; Male; Mouth Protectors; Neuroacanthocytosis; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Self-Injurious Behavior | 2008 |
An uncommon case of hypersexual behaviour with frotteurism.
Topics: Antidepressive Agents, Second-Generation; Child; Clonazepam; Depression; Female; Fluoxetine; GABA Modulators; Humans; Paraphilic Disorders | 2010 |
Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
Topics: Amlodipine; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Raynaud Disease; Schizophrenia; Vasodilator Agents | 2011 |
Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon?
Topics: Aripiprazole; Bipolar Disorder; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Piperazines; Quinolones; Recurrence | 2012 |
Evidence of a suffocation alarm system sensitive to clinically-effective treatments with the panicolytics clonazepam and fluoxetine.
Topics: Animals; Asphyxia; Clonazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Fluoxetine; Male; Panic Disorder; Potassium Cyanide; Rats | 2014 |
[Buccolingual dyskinesia with justified hallucinations].
Topics: Alcoholism; Benzodiazepines; Clonazepam; Depressive Disorder; Dibenzothiazepines; Disulfiram; Female; Fluoxetine; Foreign Bodies; Hallucinations; Humans; Middle Aged; Movement Disorders; Olanzapine; Pharynx; Quetiapine Fumarate; Tetrabenazine; Tongue Habits | 2014 |
The side-by-side exploratory test: a simple automated protocol for the evaluation of adult zebrafish behavior simultaneously with social interaction.
Topics: Animals; Bromazepam; Buspirone; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Fear; Female; Fluoxetine; Male; Pattern Recognition, Automated; Psychological Tests; Psychotropic Drugs; Social Behavior; Software; Stress, Psychological; Vision, Ocular; Zebrafish | 2015 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; GABA Modulators; Humans; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2017 |
Therapeutic challenges in comorbid obsessive compulsive disorder with substance use.
Topics: Adrenergic alpha-2 Receptor Agonists; Clonazepam; Clonidine; Combined Modality Therapy; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders | 2018 |
Fear.
Topics: Anticonvulsants; Anxiety; Clonazepam; Depression; Family Practice; Fear; Female; Fluoxetine; Humans; Internship and Residency; Patient Care; Selective Serotonin Reuptake Inhibitors | 2019 |
Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Topics: Androgens; Animals; Carbamazepine; Central Nervous System Agents; CHO Cells; Clonazepam; Cricetinae; Cricetulus; Estrogen Receptor alpha; Estrogens; Fluoxetine; Glucocorticoids; Luciferases, Firefly; Paroxetine; Receptors, Androgen; Receptors, Glucocorticoid; Sertraline; Thyroid Gland | 2022 |